How can we overcome the challenges of delivering advanced therapies to patients?

Many new targeted therapies, such as biologics, require complex cold chain logistics due to their instability at room temperature – sometimes even needing -80°C storage. In this video, TTP’s Device Innovation Lead, Matt Parker and Head of Respiratory, Svilen Savov discuss promising reconstitution solutions to simplify the process for patients, particularly in at-home settings. With a focus on automation, ease of use and adaptability, innovation in device development is essential for improving therapy administration, reducing environmental impact, and making these treatments more accessible and sustainable.